Ironwood Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Almirall EUR 43.02M 8.82M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amarin USD -16755000 35.77M 2025-03
Ardelyx USD 8.12M 5.89M 2024-12
Astellas Pharma JPY 92.54B 29.02B 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Charles River Laboratories USD 132.33M 57.66M 2025-06
Exact Sciences USD -2148000 93.86M 2025-06
Halozyme Therapeutics USD 202.44M 60.91M 2025-06
Incyte USD 310.82M 105.66M 2025-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
MacroGenics USD -16587000 70.78M 2024-12
Moderna USD -907000000 143M 2025-06
Myriad Genetics USD -29000000 10M 2025-03
Pacira USD 10.23M 8.24M 2025-06
PTC Therapeutics USD 970.22M 1.03B 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Takeda JPY 184.56B 259.5B 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06


Ironwood Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.